Abeona Therapeutics Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Abeona Therapeutics Stock Summary

Abeona Therapeutics competes with Reviva Pharmaceuticals, Athira Pharma, Fortress Biotech, ACADIA Pharmaceuticals, and Cabaletta Bio. Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Abeona Therapeutics Inc. was incorporated in 1974 and is headquartered in New York, New York. Abeona Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 90 people.

Abeona Therapeutics Key Financial Ratios

Abeona Therapeutics Key Balance Sheet Accounts

Abeona Therapeutics Key Income Statement Accounts

Abeona Therapeutics Key Cash Accounts

Abeona Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Abeona Therapeutics's current stock value. Our valuation model uses many indicators to compare Abeona Therapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Abeona Therapeutics competition to find correlations between indicators driving Abeona Therapeutics's intrinsic value. More Info.Abeona Therapeutics is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At this time, Abeona Therapeutics' Return On Equity is very stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Abeona Therapeutics' earnings, one of the primary drivers of an investment's value.

Abeona Therapeutics Systematic Risk

Today, most investors in Abeona Therapeutics Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Abeona Therapeutics' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Abeona Therapeutics growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Abeona Therapeutics help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Abeona Therapeutics. We use our internally-developed statistical techniques to arrive at the intrinsic value of Abeona Therapeutics based on widely used predictive technical indicators. In general, we focus on analyzing Abeona Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Abeona Therapeutics's daily price indicators and compare them against related drivers.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Abeona Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. To learn how to invest in Abeona Stock, please use our How to Invest in Abeona Therapeutics guide.You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Abeona Therapeutics. If investors know Abeona will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Abeona Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Abeona Therapeutics is measured differently than its book value, which is the value of Abeona that is recorded on the company's balance sheet. Investors also form their own opinion of Abeona Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Abeona Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Abeona Therapeutics' market value can be influenced by many factors that don't directly affect Abeona Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Abeona Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Abeona Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Abeona Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.